103 related articles for article (PubMed ID: 26178291)
1. Testicular orphan nuclear receptor 4 is associated with the radio-sensitivity of prostate cancer.
Yu S; Wang M; Ding X; Xia L; Chen B; Chen Y; Zhang Z; Niu Y; Li G; Chang C
Prostate; 2015 Oct; 75(14):1632-42. PubMed ID: 26178291
[TBL] [Abstract][Full Text] [Related]
2. Increased chemosensitivity via targeting testicular nuclear receptor 4 (TR4)-Oct4-interleukin 1 receptor antagonist (IL1Ra) axis in prostate cancer CD133+ stem/progenitor cells to battle prostate cancer.
Yang DR; Ding XF; Luo J; Shan YX; Wang R; Lin SJ; Li G; Huang CK; Zhu J; Chen Y; Lee SO; Chang C
J Biol Chem; 2013 Jun; 288(23):16476-16483. PubMed ID: 23609451
[TBL] [Abstract][Full Text] [Related]
3. Differential roles of PPARγ vs TR4 in prostate cancer and metabolic diseases.
Liu S; Lin SJ; Li G; Kim E; Chen YT; Yang DR; Tan MH; Yong EL; Chang C
Endocr Relat Cancer; 2014 Jun; 21(3):R279-300. PubMed ID: 24623743
[TBL] [Abstract][Full Text] [Related]
4. TR4 nuclear receptor promotes prostate cancer metastasis via upregulation of CCL2/CCR2 signaling.
Ding X; Yang DR; Lee SO; Chen YL; Xia L; Lin SJ; Yu S; Niu YJ; Li G; Chang C
Int J Cancer; 2015 Feb; 136(4):955-64. PubMed ID: 24975468
[TBL] [Abstract][Full Text] [Related]
5. TR4 nuclear receptor functions as a tumor suppressor for prostate tumorigenesis via modulation of DNA damage/repair system.
Lin SJ; Lee SO; Lee YF; Miyamoto H; Yang DR; Li G; Chang C
Carcinogenesis; 2014 Jun; 35(6):1399-406. PubMed ID: 24583925
[TBL] [Abstract][Full Text] [Related]
6. Targeting TR4 nuclear receptor suppresses prostate cancer invasion via reduction of infiltrating macrophages with alteration of the TIMP-1/MMP2/MMP9 signals.
Ding X; Yang DR; Xia L; Chen B; Yu S; Niu Y; Wang M; Li G; Chang C
Mol Cancer; 2015 Jan; 14(1):16. PubMed ID: 25623427
[TBL] [Abstract][Full Text] [Related]
7. NBN gain is predictive for adverse outcome following image-guided radiotherapy for localized prostate cancer.
Berlin A; Lalonde E; Sykes J; Zafarana G; Chu KC; Ramnarine VR; Ishkanian A; Sendorek DH; Pasic I; Lam WL; Jurisica I; van der Kwast T; Milosevic M; Boutros PC; Bristow RG
Oncotarget; 2014 Nov; 5(22):11081-90. PubMed ID: 25415046
[TBL] [Abstract][Full Text] [Related]
8. DNA-PKcs Expression Is a Predictor of Biochemical Recurrence After Permanent Iodine 125 Interstitial Brachytherapy for Prostate Cancer.
Molina S; Guerif S; Garcia A; Debiais C; Irani J; Fromont G
Int J Radiat Oncol Biol Phys; 2016 Jul; 95(3):965-972. PubMed ID: 27113564
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA-145 Modulates Tumor Sensitivity to Radiation in Prostate Cancer.
Gong P; Zhang T; He D; Hsieh JT
Radiat Res; 2015 Dec; 184(6):630-8. PubMed ID: 26632856
[TBL] [Abstract][Full Text] [Related]
10. The role of testicular nuclear receptor 4 in chemo-resistance of docetaxel in castration-resistant prostate cancer.
Chen B; Yu S; Ding X; Jing C; Xia L; Wang M; Matro E; Rehman F; Niu Y; Li G; Chang C
Cancer Gene Ther; 2014 Oct; 21(10):411-5. PubMed ID: 25104727
[TBL] [Abstract][Full Text] [Related]
11. Targeting the radiation-induced TR4 nuclear receptor-mediated QKI/circZEB1/miR-141-3p/ZEB1 signaling increases prostate cancer radiosensitivity.
Chen D; Chou FJ; Chen Y; Tian H; Wang Y; You B; Niu Y; Huang CP; Yeh S; Xing N; Chang C
Cancer Lett; 2020 Dec; 495():100-111. PubMed ID: 32768524
[TBL] [Abstract][Full Text] [Related]
12. The Differential Effects of Anti-Diabetic Thiazolidinedione on Prostate Cancer Progression Are Linked to the TR4 Nuclear Receptor Expression Status.
Lin SJ; Lin CY; Yang DR; Izumi K; Yan E; Niu X; Chang HC; Miyamoto H; Wang N; Li G; Chang C
Neoplasia; 2015 Apr; 17(4):339-47. PubMed ID: 25925376
[TBL] [Abstract][Full Text] [Related]
13. Ex vivo γH2AX assay for tumor radiosensitivity in primary prostate cancer patients and correlation with clinical parameters.
Marinescu IM; Rogg M; Spohn S; von Büren M; Kamps M; Jilg CA; Fountzila E; Papadopoulou K; Ceci L; Bettermann A; Ruf J; Benndorf M; Adebahr S; Zips D; Grosu AL; Schell C; Zamboglou C
Radiat Oncol; 2022 Oct; 17(1):163. PubMed ID: 36199143
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of N-acetylglucosaminyltransferase V enhances sensitivity of radiotherapy in human prostate cancer.
Huang H; Chen W; Liu Q; Wei T; Zhu W; Meng H; Guo L; Zhang J
Biochem Biophys Res Commun; 2014 Aug; 451(3):345-51. PubMed ID: 25117443
[TBL] [Abstract][Full Text] [Related]
15. TR4 nuclear receptor enhances prostate cancer initiation via altering the stem cell population and EMT signals in the PPARG-deleted prostate cells.
Lin SJ; Yang DR; Wang N; Jiang M; Miyamoto H; Li G; Chang C
Oncoscience; 2015; 2(2):142-50. PubMed ID: 25859557
[TBL] [Abstract][Full Text] [Related]
16. TR4 Nuclear Receptor Different Roles in Prostate Cancer Progression.
Lin SJ; Yang DR; Li G; Chang C
Front Endocrinol (Lausanne); 2015; 6():78. PubMed ID: 26074876
[TBL] [Abstract][Full Text] [Related]
17. Oligophrenin-1 is associated with cell adhesion and migration in prostate cancer.
Goto K; Oue N; Hayashi T; Shinmei S; Sakamoto N; Sentani K; Teishima J; Matsubara A; Yasui W
Pathobiology; 2014; 81(4):190-8. PubMed ID: 25170626
[TBL] [Abstract][Full Text] [Related]
18. Long-term follow-up of patients with prostate cancer and nodal metastases treated by pelvic lymphadenectomy and radical prostatectomy: the positive impact of adjuvant radiotherapy.
Da Pozzo LF; Cozzarini C; Briganti A; Suardi N; Salonia A; Bertini R; Gallina A; Bianchi M; Fantini GV; Bolognesi A; Fazio F; Montorsi F; Rigatti P
Eur Urol; 2009 May; 55(5):1003-11. PubMed ID: 19211184
[TBL] [Abstract][Full Text] [Related]
19. TR2 and TR4 Orphan Nuclear Receptors: An Overview.
Lin SJ; Yang DR; Yang G; Lin CY; Chang HC; Li G; Chang C
Curr Top Dev Biol; 2017; 125():357-373. PubMed ID: 28527578
[TBL] [Abstract][Full Text] [Related]
20. NOXA and PUMA expression add to clinical markers in predicting biochemical recurrence of prostate cancer patients in a survival tree model.
Diallo JS; Aldejmah A; Mouhim AF; Péant B; Fahmy MA; Koumakpayi IH; Sircar K; Bégin LR; Mes-Masson AM; Saad F
Clin Cancer Res; 2007 Dec; 13(23):7044-52. PubMed ID: 18056181
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
